As it awaits key read­out, He­p­i­on boosts con­fi­dence in NASH drug hope­ful via short­er study

He­p­i­on Phar­ma­ceu­ti­cals said Mon­day morn­ing its drug for non­al­co­holic steato­hep­ati­tis, or NASH, im­proved liv­er func­tion ac­cord­ing to an ex­per­i­men­tal di­ag­nos­tic and …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER